Tracked deals
3
3 tracked deals across 2023-2025.
Operating Company
Healthcare
Bluesight
Alexandria, Virginia, United States
Bluesight powers hospital operations with intelligence that simplifies inventory management, procurement, and compliance for hospital pharmacies and health systems. The platform supports medication intelligence, medication management workflows, and drug diversion/healthcare compliance analytics.
- Focus Areas
- Medication intelligence, Medication management software, Drug diversion analytics
- Website
- bluesight.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
2 buyout · 1 addon
Bluesight Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
- Buyer
- Bluesight, Thoma Bravo
- Target
- Protenus
- Industry
- Healthcare Services
- Location
- Maryland, United States
- Type
- Buyout
Bluesight, a provider of inventory management, procurement, and compliance solutions for hospitals, has acquired Protenus, a Baltimore-based healthcare compliance analytics platform. The acquisition expands Bluesight's drug diversion and patient privacy monitoring capabilities, combining AI-driven compliance analytics with Bluesight's hospital and pharmacy operations intelligence.
-
October 17, 2024
- Buyer
- Bluesight
- Target
- Sectyr
- Industry
- Healthcare Services
- Location
- Arizona, United States
- Type
- Buyout
Bluesight, a provider of Medication Intelligence solutions, has acquired Sectyr, a cloud-based compliance and audit management platform focused on 340B program management. The acquisition adds 340B audit and compliance capabilities to Bluesight’s product suite to improve pharmacy compliance, audit readiness, and operational visibility for hospitals and health systems.
-
- Buyer
- Thoma Bravo, Bluesight, Monroe Capital LLC
- Target
- Medacist
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Type
- Addon
Thoma Bravo made a strategic growth investment in Bluesight to support Bluesight's acquisition of Medacist, combining two medication-management and drug-diversion analytics businesses into a single hospital pharmacy software platform. The combined company will expand Bluesight's medication intelligence capabilities and serve more than 2,000 hospitals across North America; committed financing was led by Monroe Capital and existing investor New Leaf Ventures remains invested. Financial terms were not disclosed.
Related Acquisition Pages
Selling a company? Get in front of buyers like Bluesight
Turn tracked acquisition activity into an outreach-ready buyer list.